Effects of Transcranial Electrical Stimulation in Chronic Stress
NEUROSTIM
1 other identifier
interventional
100
1 country
1
Brief Summary
This clinical trial aims to determine if Transcranial electrical stimulation by direct current (tDCS) and transauricular Vagus Nerve Stimulation (tVNS) treatments are effective in reducing stress symptoms, distress and improving sleep quality in adults. The main questions it aims to answer are:
- Determine if tDCS effectively reduces the intensity of stress symptoms in adults.
- Determine if tDCS is effective in reducing levels of distress in adults.
- Determine if tDCS is effective in improving sleep quality.
- Determine if tVNS is effective in reducing the intensity of stress symptoms in adults.
- Determine if tVNS is effective in reducing levels of distress in adults.
- Determine if tVNS is effective in improving sleep quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 6, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
February 6, 2025
December 1, 2024
1.8 years
December 5, 2024
February 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Stress Symptoms assessment
Stress will be assessed using self reported Lipp's Inventory of Stress Symptoms for Adults (LISS). The LISS consists of a questionnaire that assesses physical and psychological symptoms of stress across three time frames: alert (ranging from 0 to 15), resistance (ranging from 0 to 15), quasi-exhaustion or exhaustion (ranging from 0 to 23). Higher scores mean a worse outcome.
From enrollment to follow up at 1 month
Perceived Stress assessment
Perceived Stress will be assessed using the Perceived Stress Scale (PSS-10). The test ranges from 0 (min) to 40 (max). Higher scores mean a a worst outcome.
From enrollment to follow up at 1 month
Secondary Outcomes (2)
Distress Assessment
From enrollment to followup at 1 month
Sleep Quality
From enrollment to follow up at 1 month
Study Arms (4)
tDCS True Modulation
EXPERIMENTALParticipants will be delivered true treatment for 20 minutes each session
tDCS Sham group
SHAM COMPARATORSham group will be delivers a simulated treatment; the current will be applied for only 60 seconds, with the setup remaining in place for 20 minutes.
tVNS True
EXPERIMENTALFor true tVNS stimulation, the technique will be performed with the electrodes positioned on the upper concha of the left ear, using gel for better current distribution.
tVNS Sham
SHAM COMPARATORFor sham tVNS stimulation, the technique will be performed in the same way as true stimulation; however, the device will be programmed to deliver 0 Hz.
Interventions
For true tDCS, the technique will be performed with the anode over the right dorsolateral prefrontal cortex and the cathode over the left dorsolateral prefrontal cortex, positioned at F4 and F3, respectively, according to the International 10/20 Electrode Placement System. The current intensity will be set to 2 milliamperes (mA) for 20 minutes over five consecutive days.
For true tVNS stimulation, the technique will be performed with the electrodes positioned on the upper concha of the left ear, using gel for better current distribution.
Eligibility Criteria
You may qualify if:
- individuals previously diagnosed with stress.
- Obtain a score above 4 on the Lipp Adult Stress Symptom Inventory (ISSL);
- Must be able to read and understand the purpose of the research and respond to the assessment instruments.
- Must acknowledge and agree with the informed consent form.
You may not qualify if:
- smokers;
- be pregnant;
- initiation and/or change in psychotropic drug dosage in the last three months;
- use of anxiolytics or antidepressants;
- substance dependence;
- history of dizziness or seizures;
- signs of severity and/or indications for hospitalization or psychotherapy;
- diagnosis of depression; diagnosis of anxiety; bipolar mood disorder with depressive, manic, or hypomanic symptoms in the past year;
- schizophrenia or other psychotic disorders;
- autism;
- diagnosis of epilepsy or use of anticonvulsants;
- contraindications for tDCS (metal implants, tumor, previous brain surgery, significant cranioencephalic anatomical alterations);
- contraindications for non-invasive vagus nerve stimulation (cochlear implant, ear plastic surgery, ear malformation);
- adverse effects detected in the group treated with tDCS and tVNS, including itching, tingling, headache, burning sensation, and discomfort.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Egas Moniz Scholl Of Health and Science
Almada, Setúbal District, Portugal
Related Publications (3)
Brunoni AR, Nitsche MA, Bolognini N, Bikson M, Wagner T, Merabet L, Edwards DJ, Valero-Cabre A, Rotenberg A, Pascual-Leone A, Ferrucci R, Priori A, Boggio PS, Fregni F. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012 Jul;5(3):175-195. doi: 10.1016/j.brs.2011.03.002. Epub 2011 Apr 1.
PMID: 22037126BACKGROUNDAlyan E, Saad NM, Kamel N, Yusoff MZ, Zakariya MA, Rahman MA, Guillet C, Merienne F. Frontal Electroencephalogram Alpha Asymmetry during Mental Stress Related to Workplace Noise. Sensors (Basel). 2021 Mar 11;21(6):1968. doi: 10.3390/s21061968.
PMID: 33799722BACKGROUNDLoftus AM, Yalcin O, Baughman FD, Vanman EJ, Hagger MS. The impact of transcranial direct current stimulation on inhibitory control in young adults. Brain Behav. 2015 May;5(5):e00332. doi: 10.1002/brb3.332. Epub 2015 Mar 19.
PMID: 25874165BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 5, 2024
First Posted
February 6, 2025
Study Start
March 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
April 1, 2027
Last Updated
February 6, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share